| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0004 | 1 |